tiprankstipranks
Oculis Holding (OCS)
NASDAQ:OCS

Compare Oculis Holding (OCS) vs. Competitors

189 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Oculis Holding
$27.34
$1.56B
-8.77
84.73%
5 Buy
0 Hold
0 Sell
Strong Buy
EyePoint Pharmaceuticals
$14.17
$1.18B
-5.61
243.10%
10 Buy
0 Hold
0 Sell
Strong Buy
Spyre Therapeutics
$51.98
$4.08B
-45.32
340.51%
10 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$320.22
$8.92B
-21.87
1019.65%
13 Buy
1 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$8.30
$813.24M
-6.70
-33.58%
3 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$30.30
$535.49M
-10.19
62.11%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCS
Oculis Holding
27.34
11.10
68.35%
EYPT
EyePoint Pharmaceuticals
14.17
9.60
210.07%
SYRE
Spyre Therapeutics
51.98
38.61
288.78%
PRAX
Praxis Precision Medicines
320.22
289.37
937.99%
SPRY
ARS Pharmaceuticals
8.19
-5.15
-38.61%
UPB
Upstream Bio, Inc.
9.84
3.31
50.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts